Results 251 to 260 of about 29,464,938 (335)
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
IHIBE: A Hierarchical and Delegated Access Control Mechanism for IoT Environments. [PDF]
Purnama H, Mambo M.
europepmc +1 more source
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor +2 more
wiley +1 more source
Comparative analysis of identity management, access control, and authorization practices in public and private universities. [PDF]
Mollakuqe E, Dimitrova V.
europepmc +1 more source
Insights into a long life without cancer: The case of the bowhead whale
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley +1 more source
SDACS: Blockchain-Based Secure and Dynamic Access Control Scheme for Internet of Things. [PDF]
Gong Q +7 more
europepmc +1 more source
PatCen: A blockchain-based patient-centric mechanism for the granular access control of infectious disease-related test records. [PDF]
Yakubu BM +3 more
europepmc +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
Blockchain-based proxy re-encryption access control method for biological risk privacy protection of agricultural products. [PDF]
Wang S +5 more
europepmc +1 more source

